National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

sunitinib malate (soo-NIH-tih-nib MA-layt)

 A drug used to treat gastrointestinal stromal tumors (GIST) that have not responded to treatment with imatinib mesylate (Gleevec). Sunitinib malate is also used to treat advanced kidney cancer and is being studied in the treatment of other types of cancer. It is a type of tyrosine kinase inhibitor, a type of vascular endothelial growth factor (VEGF) receptor inhibitor, and a type of angiogenesis inhibitor. Also called SU011248, SU11248, sunitinib, and Sutent.



Previous Definitions:sulfuric acid, sulindac, sun protection factor, Sun's Soup, sunitinib
Next Definitions:sunscreen, superficial, superfractionated radiation therapy, superior vena cava, superior vena cava syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov